![Sirolimus effects on cancer incidence after kidney transplantation: a meta‐analysis - Yanik - 2015 - Cancer Medicine - Wiley Online Library Sirolimus effects on cancer incidence after kidney transplantation: a meta‐analysis - Yanik - 2015 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ee276b90-2e3d-4bfb-9767-84f6ecb5e5a7/cam4487-fig-0001-m.jpg)
Sirolimus effects on cancer incidence after kidney transplantation: a meta‐analysis - Yanik - 2015 - Cancer Medicine - Wiley Online Library
Early conversion to a CNI-free immunosuppression with SRL after renal transplantation—Long-term follow-up of a multicenter trial | PLOS ONE
![Frontiers | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients Frontiers | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients](https://www.frontiersin.org/files/Articles/426937/fonc-09-00160-HTML/image_m/fonc-09-00160-g001.jpg)
Frontiers | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
Dietary Immunosuppressants Do Not Enhance UV-Induced Skin Carcinogenesis, and Reveal Discordance between p53-Mutant Early Clones
![Sirolimus effects on cancer incidence after kidney transplantation: a meta‐analysis - Yanik - 2015 - Cancer Medicine - Wiley Online Library Sirolimus effects on cancer incidence after kidney transplantation: a meta‐analysis - Yanik - 2015 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/78a40626-bfc3-41bc-8f71-6719c1c4e402/cam4.2015.4.issue-9.cover.jpg)
Sirolimus effects on cancer incidence after kidney transplantation: a meta‐analysis - Yanik - 2015 - Cancer Medicine - Wiley Online Library
![IJMS | Free Full-Text | Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword? IJMS | Free Full-Text | Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?](https://www.mdpi.com/ijms/ijms-20-02194/article_deploy/html/images/ijms-20-02194-g001.png)
IJMS | Free Full-Text | Programmed Cell Death 1 (PD-1) Inhibitors in Renal Transplant Patients with Advanced Cancer: A Double-Edged Sword?
![PDF) Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months PDF) Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months](https://www.researchgate.net/publication/324548898/figure/fig2/AS:616256185057280@1523938332410/Malignancies-on-mTOR-I-monotherapy-or-combined-with-CNIs-versus-CNI-treatment-post_Q320.jpg)